News & Insights

The SEC will permit mandatory shareholder arbitration in public company governance starting September 19, 2025, marking a significant shift in federal securities law claims

Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle

On December 19, 2023, a panel of the U.S. Court of Appeals for the Fifth Circuit vacated the share repurchase disclosure rules adopted by the U.S. Securities and Exchange Commission (SEC) in May 2023. Learn more here. 

Alaffia Health, the leader in agentic AI for health plan claims operations, announces its $55 million Series B financing.

Contineum Therapeutics, a clinical-stage biopharmaceutical company, announces the pricing of an upsized underwritten public offering of 7,346,938 shares of its Class A common stock at a public offering price of $12.25 per share.

Gunderson Dettmer represented long-time client BillionToOne, Inc. (Nasdaq: BLLN), a molecular diagnostics company on a mission to make powerful and accessible genetic tests available to all, in its initial public offering of 4.6 million shares of Class A common stock at a price to the public of $60 per share, generating approximately $273.1 billion in aggregate gross proceeds.

For the 11th consecutive year, Gunderson Dettmer has been named the most active VC law firm globally by the 2024 PitchBook Global League Tables.

Gunderson Dettmer fuels Generative AI education in venture capital. Explore diverse AI resources: articles, client insights, events, podcasts, and webinars – all enhancing your engagement with this dynamic field.

Extension of Traditional IPO Investor Protections to SPAC Transactions Will Significantly Increase Costs, Complexity and Potential Liability for Market Participants Throughout the SPAC Lifecycle